A retrospective study to assess real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients treated in United States clinical practices
Latest Information Update: 25 Feb 2021
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Feb 2021 New trial record
- 17 Jan 2021 Results presented at the 2021 Gastrointestinal Cancers Symposium